Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Stereotaxis

Explore full profile

Stereotaxis develops robotic cardiology instrument navigation systems that enhances the treatment of arrhythmias and coronary diseases

St. Louis, United StatesFounded 1990Health Tech & Medtech
Valuation $140M Market cap · 2026
Revenue $39M Latest reported FY

About Stereotaxis

Stereotaxis is a leading MedTech company specializing in innovative robotic technologies for the treatment of arrhythmias. The company operates in the healthcare sector, providing advanced robotic catheter ablation systems that enable precise and safe treatment of heart rhythm disorders. Stereotaxis primarily serves healthcare professionals, including physicians and hospitals, who are involved in the treatment of arrhythmias. The company’s business model revolves around the development, manufacturing, and sale of its robotic systems, as well as providing ongoing support and maintenance services. Revenue is generated through the sale of these systems and associated services. Stereotaxis is recognized for its Robotic Magnetic Navigation (RMN) System, which has been successfully implemented in various healthcare facilities, enhancing the precision and safety of arrhythmia treatments. The company continues to innovate and expand its market presence, aiming to improve patient outcomes and advance the field of endovascular treatment.

Source: Dealroom company data

At a glance

Status
Listed
Founded
1990
Headquarters
St. Louis, United States
Listing
IPO 2004
Sector
Health Tech & Medtech
Power Law
Colt$25–100M revenue

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Investors

8 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A5 investors entered at this stage

  • Ascension
  • DFJ Portage Ventures
  • Alafi Capital
  • Stifel
  • A.G. Edwards & Sons

Series B and later3 investors entered at this stage

  • Advantage Capital
  • Redmile Group
  • Parkman Healthcare Partners

Talent

Book a demo to see the people
Team profiled 30 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
11 countries with
team presence
🇺🇸 United States84.1%
🇳🇱 Netherlands2.8%
🇨🇳 China2.8%
🇩🇪 Germany1.9%
🇫🇮 Finland1.9%
Top 5 of 11 shown
Web traffic by country
6.6K monthly visits
across markets
🇺🇸 United States90.9%
🇫🇷 France6.1%
🇮🇳 India3%
🇵🇰 Pakistan1.5%
Top 4 markets shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Stereotaxis on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Stereotaxis on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles